WuXi PharmaTech (WX) Misses Q2 EPS by 1c, Reconfirms FY Rev Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to WuXi PharmaTech (WX) Misses Q2 EPS by 1c, Reconfirms FY Rev Guidance

WuXi PharmaTech Announces Second-Quarter 2015 Results

August 13, 2015 4:30 PM EDT

SHANGHAI, Aug. 13, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.("WuXi") (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the second quarter of 2015. 

Second-Quarter 2015 Highlights

Net Revenues Increased 18.8% Year Over Year to $194.1 Million Net Revenues for Laboratory Services Grew 17.9% Year Over Year to $123.5 Million Net Revenues for Small-Molecule Manufacturing Services Increased 10.0% Year Over Year to $45.9 Million Net... More